Lifespan of human amniotic fluid-derived multipotent mesenchymal stromal cells

By Miranda-Sayago Jose Maria   Fernáández-Arcas Nieves   Benito Carmen   Reyes-Engel Armando   Carrera Jorge   Alonso Antonio  

Cytotherapy, Vol. 13, Iss. 5, 2011-05 ,pp. : 572-581

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Fetal and adult multipotent mesenchymal stromal cells are killed by different pathways

By Göötherströöm Cecilia   Lundqvist Andreas   Duprez Ida Rasmusson   Childs Richard   Berg Louise   le Blanc Katarina  

Cytotherapy, Vol. 13, Iss. 3, 2011-03 ,pp. : 269-278

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Heterogeneity of mesenchymal stromal cell preparations

By Ho AD   Wagner W.   Franke W.  

Cytotherapy, Vol. 10, Iss. 4, 2008-01 ,pp. : 320-330

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

By Dominici M   Le Blanc K   Mueller I   Slaper-Cortenbach I   Marini Fc   Krause Ds   Deans Rj   Keating A   Prockop Dj   Horwitz Em  

Cytotherapy, Vol. 8, Iss. 4, 2006-08 ,pp. : 315-317

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM

By Müller I   Kordowich S   Holzwarth C   Spano C   Isensee G   Staiber A   Viebahn S   Gieseke F   Langer H   Gawaz MP   Horwitz EM   Conte P   Handgretinger R   Dominici M  

Cytotherapy, Vol. 8, Iss. 5, 2006-11 ,pp. : 437-444

Ashgate Publishing Ltd

Access to resources Recommend Favorite